124 related articles for article (PubMed ID: 27410930)
21. Immediate response to prasugrel loading in patients with ST-elevation myocardial infarction: Predictors and outcome.
Koifman E; Beigel R; Herscovici R; Fefer P; Rozenberg N; Sabbag A; Biton Y; Segev A; Shechter M; Asher E; Matetzky S
Thromb Res; 2016 Aug; 144():176-81. PubMed ID: 27386796
[TBL] [Abstract][Full Text] [Related]
22. Clinical significance of platelet reactivity during prasugrel therapy in patients with acute myocardial infarction.
Sato T; Namba Y; Kashihara Y; Tanaka M; Fuke S; Yumoto A; Saito H
J Cardiol; 2017 Jul; 70(1):35-40. PubMed ID: 27836373
[TBL] [Abstract][Full Text] [Related]
23. Prasugrel and ticagrelor compared to clopidogrel in non-ST-segment elevation acute coronary syndromes undergoing percutaneous coronary interventions: Certainties and uncertainties.
De Servi S; Cavallini C; Leonardi S; Ferlini M
Int J Cardiol; 2015 Feb; 181():443-5. PubMed ID: 25590784
[No Abstract] [Full Text] [Related]
24. Acute chest syndrome: sickle cell disease.
Paul RN; Castro OL; Aggarwal A; Oneal PA
Eur J Haematol; 2011 Sep; 87(3):191-207. PubMed ID: 21615795
[TBL] [Abstract][Full Text] [Related]
25. Acute coronary syndromes and coronary intervention.
Lüscher TF
Eur Heart J; 2015 Feb; 36(6):323-4. PubMed ID: 25660518
[No Abstract] [Full Text] [Related]
26. Health-related quality of life outcomes with prasugrel among medically managed non-ST-segment elevation acute coronary syndrome patients: Insights from the Targeted Platelet Inhibition to Clarify the Optimal Strategy to Medically Manage Acute Coronary Syndromes (TRILOGY ACS) trial.
Kaul P; Ohman EM; Knight JD; Anstrom KJ; Roe MT; Boden WE; Hochman JS; Gašparović V; Armstrong PW; McCollam P; Fakhouri W; Cowper P; Davidson-Ray L; Clapp-Channing N; White HD; Fox KA; Prabhakaran D; Mark DB;
Am Heart J; 2016 Aug; 178():55-64. PubMed ID: 27502852
[TBL] [Abstract][Full Text] [Related]
27. Comparison of prasugrel and clopidogrel-treated patients with acute coronary syndrome undergoing percutaneous coronary intervention: A propensity score-matched analysis of the Acute Myocardial Infarction in Switzerland (AMIS)-Plus Registry.
Kurz DJ; Radovanovic D; Seifert B; Bernheim AM; Roffi M; Pedrazzini G; Windecker S; Erne P; Eberli FR
Eur Heart J Acute Cardiovasc Care; 2016 Feb; 5(1):13-22. PubMed ID: 25614494
[TBL] [Abstract][Full Text] [Related]
28. Ascertainment, classification, and impact of neoplasm detection during prolonged treatment with dual antiplatelet therapy with prasugrel vs. clopidogrel following acute coronary syndrome.
Roe MT; Cyr DD; Eckart D; Schulte PJ; Morse MA; Blackwell KL; Ready NE; Zafar SY; Beaven AW; Strickler JH; Onken JE; Winters KJ; Houterloot L; Zamoryakhin D; Wiviott SD; White HD; Prabhakaran D; Fox KA; Armstrong PW; Ohman EM;
Eur Heart J; 2016 Jan; 37(4):412-22. PubMed ID: 26637834
[TBL] [Abstract][Full Text] [Related]
29. High Platelet Reactivity in Patients with Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention: Randomised Controlled Trial Comparing Prasugrel and Clopidogrel.
Geisler T; Booth J; Tavlaki E; Karathanos A; Müller K; Droppa M; Gawaz M; Yanez-Lopez M; Davidson SJ; Stables RH; Banya W; Zaman A; Flather M; Dalby M
PLoS One; 2015; 10(8):e0135037. PubMed ID: 26317618
[TBL] [Abstract][Full Text] [Related]
30. Reanalysis or redefinition of the hypothesis?
Ciolino JD; Carter RE
Eur Heart J; 2015 Feb; 36(6):340-1. PubMed ID: 25139897
[No Abstract] [Full Text] [Related]
31. Inter-patient variability of platelet reactivity in patients treated with prasugrel and ticagrelor.
Siller-Matula JM; Akca B; Neunteufl T; Maurer G; Lang IM; Kreiner G; Berger R; Delle-Karth G
Platelets; 2016 Jun; 27(4):373-7. PubMed ID: 26555925
[TBL] [Abstract][Full Text] [Related]
32. Thienopyridines in Acute Coronary Syndrome.
Goodwin MM; Desilets AR; Willett KC
Ann Pharmacother; 2011 Feb; 45(2):207-17. PubMed ID: 21304037
[TBL] [Abstract][Full Text] [Related]
33. The role of prasugrel in the management of acute coronary syndromes: a systematic review.
Spartalis M; Tzatzaki E; Spartalis E; Damaskos C; Athanasiou A; Moris D; Politou M
Eur Rev Med Pharmacol Sci; 2017 Oct; 21(20):4733-4743. PubMed ID: 29131238
[TBL] [Abstract][Full Text] [Related]
34. Addressing challenges of clinical trials in acute pain: The Pain Management of Vaso-occlusive Crisis in Children and Young Adults with Sickle Cell Disease Study.
Nottage KA; Hankins JS; Faughnan LG; James DM; Richardson J; Christensen R; Kang G; Smeltzer M; Cancio MI; Wang WC; Anghelescu DL
Clin Trials; 2016 Aug; 13(4):409-16. PubMed ID: 27000103
[TBL] [Abstract][Full Text] [Related]
35. Impact of Proton Pump Inhibitor Use on the Comparative Effectiveness and Safety of Prasugrel Versus Clopidogrel: Insights From the Treatment With Adenosine Diphosphate Receptor Inhibitors: Longitudinal Assessment of Treatment Patterns and Events After Acute Coronary Syndrome (TRANSLATE-ACS) Study.
Jackson LR; Peterson ED; McCoy LA; Ju C; Zettler M; Baker BA; Messenger JC; Faries DE; Effron MB; Cohen DJ; Wang TY
J Am Heart Assoc; 2016 Oct; 5(10):. PubMed ID: 27792656
[TBL] [Abstract][Full Text] [Related]
36. Platelet inhibition with prasugrel in patients with acute myocardial infarction undergoing therapeutic hypothermia after cardiopulmonary resuscitation.
Flierl U; Röntgen P; Zauner F; Tongers J; Berliner D; Bauersachs J; Schäfer A
Thromb Haemost; 2016 May; 115(5):960-8. PubMed ID: 26790884
[TBL] [Abstract][Full Text] [Related]
37. Associations Between Complex PCI and Prasugrel or Clopidogrel Use in Patients With Acute Coronary Syndrome Who Undergo PCI: From the PROMETHEUS Study.
Chandrasekhar J; Baber U; Sartori S; Aquino M; Kini AS; Rao S; Weintraub W; Henry TD; Farhan S; Vogel B; Sorrentino S; Ge Z; Kapadia S; Muhlestein JB; Weiss S; Strauss C; Toma C; DeFranco A; Effron MB; Keller S; Baker BA; Pocock S; Dangas G; Mehran R
Can J Cardiol; 2018 Mar; 34(3):319-329. PubMed ID: 29475531
[TBL] [Abstract][Full Text] [Related]
38. A comparison of cangrelor, prasugrel, ticagrelor, and clopidogrel in patients undergoing percutaneous coronary intervention: A network meta-analysis.
Westman PC; Lipinski MJ; Torguson R; Waksman R
Cardiovasc Revasc Med; 2017 Mar; 18(2):79-85. PubMed ID: 28089137
[TBL] [Abstract][Full Text] [Related]
39. "Real-World" Comparison of Prasugrel With Ticagrelor in Patients With Acute Coronary Syndrome Treated With Percutaneous Coronary Intervention in the United States.
Larmore C; Effron MB; Molife C; DeKoven M; Zhu Y; Lu J; Karkare S; Lieu HD; Lee WC; Vetrovec GW
Catheter Cardiovasc Interv; 2016 Oct; 88(4):535-544. PubMed ID: 26577386
[TBL] [Abstract][Full Text] [Related]
40. Prasugrel vs. clopidogrel in contemporary Western European patients with acute coronary syndromes receiving drug-eluting stents: Comparative cost-effectiveness analysis from the BASKET-PROVE cohorts.
Wein B; Coslovsky M; Jabbari R; Galatius S; Pfisterer M; Kaiser C
Int J Cardiol; 2017 Dec; 248():20-27. PubMed ID: 28823409
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
